Following the recent appointment of former SonoSite Inc. CEO and medical ultrasound pioneer Kevin Goodwin as CEO, Australian medical device company Signostics has announced the appointment of Rick Salzar and Takatsuna Kitagawa, both former SonoSite Executives, as the company’s new Vice President of Global Distribution and Managing Director Japan, respectively.
Mr Salzar, who is based in California, has 33 years’ experience in the medical device industry, with 25 years in International Management positions for Alaris Medical Systems specialising in the intravenous drug delivery market.
In 2011, Mr Salzar moved from Alaris Medical Systems to a position as the SonoSite Vice President and General Manager of Europe, Russia and Africa. Mr Salzar’s tenure at SonoSite was credited with many notable achievements including leading the company in the reorganisation of the entire go-to-market team and strategy. Under Mr Salzar’s leadership, SonoSite also successfully launched their newest product, the X-Porte point-of-care device.
Mr Kitagawa, who is based in Japan, has 24 years’ experience in the ultrasound industry, with 10 years in management positions for SonoSite Japan.
After experience in business development roles for SonoSite Japan, Mr Kitagawa moved to a position as the company’s General Manager. Mr Kitagawa’s tenure at SonoSite was credited with many prominent achievements including receiving the Chairman’s Award and Country of the Year award. Under Mr Kitagawa’s leadership, SonoSite Japan also achieved the largest revenue and profit of all SonoSite subsidiaries outside of the US.
Chief Executive Officer of Signostics Kevin Goodwin is delighted to confirm the appointment of Mr Salzar and Mr Kitagawa. “I’m pleased to announce that we have attracted Mr Salzar and Mr Kitagawa to Signostics. They both bring us a track record of consistent reliable performance,” Mr Goodwin said.
Mr Salzar and Mr Kitagawa both said they were excited about the opportunity to join Signostics.
“I have known of Signostics for quite some time as I was an investor in needle guidance technology for line placement in anaesthesia and I was familiar with the small size and leading edge technology.
“When I learned Kevin Goodwin had joined, I was very interested in how Signostics could grow into a global ultrasound player. I was convinced that a small, agile company could develop technology faster and differentiate itself quickly from other companies in the market,” Mr Salzar said.
“Signostics has a great chance to be a global leader in the forthcoming new ultrasound market, especially in the area of point-of-care as a new ultrasound tool for everyone,” Mr Kitagawa said.
Mr Salzar and Mr Kitagawa took up their appointments from 22 June, 2015 and 1 July, 2015, respectively.